Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Considerations of sex and gender differences in preclinical and clinical trials.

Raz L, Miller VM.

Handb Exp Pharmacol. 2012;(214):127-47. doi: 10.1007/978-3-642-30726-3_7. Review.

PMID:
23027449
2.
4.

Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction.

Rochon PA, Clark JP, Binns MA, Patel V, Gurwitz JH.

CMAJ. 1998 Aug 25;159(4):321-7. Erratum in: CMAJ 1998 Sep 22;159(6):650.

6.

Sex and gender differences in clinical medicine.

Regitz-Zagrosek V, Seeland U.

Handb Exp Pharmacol. 2012;(214):3-22. doi: 10.1007/978-3-642-30726-3_1. Review.

PMID:
23027443
7.
8.

Gender differences in pharmacokinetics and pharmacodynamics.

Beierle I, Meibohm B, Derendorf H.

Int J Clin Pharmacol Ther. 1999 Nov;37(11):529-47. Review.

PMID:
10584975
9.
10.

Trials in women.

Battino D.

Epilepsy Res. 2001 May;45(1-3):141-5; discussion 147. Review.

PMID:
11461817
11.

Sex and gender in adverse drug events, addiction, and placebo.

Franconi F, Campesi I, Occhioni S, Antonini P, Murphy MF.

Handb Exp Pharmacol. 2012;(214):107-26. doi: 10.1007/978-3-642-30726-3_6. Review.

PMID:
23027448
12.

[Men and women respond differently to drugs. Hormone-dependent pharmacodynamic differences are rarely studied].

Vinge E.

Lakartidningen. 1998 Jul 8;95(28-29):3177-82. Review. Swedish.

PMID:
9700262
13.

Pharmacokinetic analysis of bioequivalence trials: implications for sex-related issues in clinical pharmacology and biopharmaceutics.

Chen ML, Lee SC, Ng MJ, Schuirmann DJ, Lesko LJ, Williams RL.

Clin Pharmacol Ther. 2000 Nov;68(5):510-21.

PMID:
11103754
14.

Alternative strategies in drug development: clinical pharmacological aspects.

Kuhlmann J.

Int J Clin Pharmacol Ther. 1999 Dec;37(12):575-83. Review.

PMID:
10599949
15.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
16.

Influence of gender on the pharmacokinetics and pharmacodynamics of drugs.

Thürmann PA, Hompesch BC.

Int J Clin Pharmacol Ther. 1998 Nov;36(11):586-90. Review.

PMID:
9849747
17.

Sociodemographic analysis of patients in radiation therapy oncology group clinical trials.

Chamberlain RM, Winter KA, Vijayakumar S, Porter AT, Roach M 3rd, Streeter O, Cox JD, Bondy ML.

Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):9-15.

PMID:
9422552
18.
19.

Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women.

Franconi F, Campesi I.

Br J Pharmacol. 2014 Feb;171(3):580-94. doi: 10.1111/bph.12362. Review.

20.

Drug use during pregnancy and breast-feeding. A classification system for drug information.

Berglund F, Flodh H, Lundborg P, Prame B, Sannerstedt R.

Acta Obstet Gynecol Scand Suppl. 1984;126:1-55.

PMID:
6393685

Supplemental Content

Support Center